Bioz

Company Overview

Snapshot

Founded in July 2013 by Daniel Levitt and Karin Lachmi, Bioz operates with 11–50 employees. The company has raised a total of $10 million across 7 funding rounds from 10 investors.

Business overview

Bioz develops an AI-driven search engine designed to optimize scientific research product identification. Leveraging patented AI technologies, the platform analyzes billions of scientific data points to provide evidence-based product ratings and recommendations. This enables researchers, lab managers, and industry leaders to make data-driven decisions when selecting reagents, instruments, or software. Bioz also offers AI solutions, including Bioz Badges and Content Hubs, for suppliers of scientific research products, integrating dynamic digital marketing widgets into e-commerce websites to display product citations from scientific publications and enhance product credibility. The company operates within the Health Tech & Life Sciences sector, focusing on digital healthcare and medical decision support.

Strategic signal

In March 2020, Bioz granted free access to its platform for all researchers in biopharma and academia to accelerate the fight against COVID-19. This initiative demonstrated the company's commitment to leveraging its AI-driven search engine for critical global health challenges, highlighting the platform's utility beyond commercial applications and its potential for significant societal impact. This move signals to investors a strong sense of corporate social responsibility and the adaptability of its technology to urgent research needs.

Company Intelligence Q&A

What is Bioz's core offering?

Bioz provides an AI-driven search engine that helps scientific researchers identify optimal products by analyzing billions of scientific data points to offer evidence-based ratings and recommendations.

When was Bioz founded and by whom?

Bioz was founded in July 2013 by Daniel Levitt and Karin Lachmi.

What significant partnership did Bioz announce in July 2020?

In July 2020, Bioz partnered with New England Biolabs to empower life science researchers in COVID-19 discovery efforts.

What was a key strategic move by Bioz in March 2020?

In March 2020, Bioz granted free access to its platform for all researchers in biopharma and academia to accelerate the fight against COVID-19, demonstrating its commitment to supporting critical scientific endeavors.

Which investors participated in Bioz's February 2019 funding round?

In February 2019, Bioz received funding from Esther Dyson and StartX (Stanford-StartX Fund).